Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Jay OlssonDO PROF ASSOCIATIONN
Physical Medicine and Rehabilitation · Melbourne, FL 32935
NPI: 1144264904
43
🟠 Elevated
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,784
Total Claims
$803K
Drug Cost
546
Beneficiaries
$1,471
Cost/Patient
Risk Score Breakdown 43/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,404 Physical Medicine and Rehabilitation providers
+312%
Opioid rate vs peers
83.3% vs 20.2% avg
+223%
Cost per patient vs peers
$1,471 vs $455 avg
+275%
Brand preference vs peers
11.8% vs 3.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 312% above Physical Medicine and Rehabilitation peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
83.3%
Opioid Rate
6,485
Opioid Claims
$610K
Opioid Cost
34.7%
Long-Acting Rate
This provider's opioid prescribing rate of 83.3% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 917 claims · $532K
Generic: 6,867 claims · $271K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 420 | $248K |
| Oxycodone Hcl/Acetaminophen | 2,126 | $86K |
| Hydrocodone Bitartrate | 80 | $55K |
| Hydrocodone/Acetaminophen | 1,310 | $38K |
| Buprenorphine | 116 | $35K |
| Oxycodone Hcl | 87 | $34K |
| Morphine Sulfate | 1,168 | $31K |
| Dextromethorphan Hbr/Quinidine | 18 | $29K |
| Tapentadol Hcl | 23 | $26K |
| Pregabalin | 20 | $24K |
| Buprenorphine Hcl/Naloxone Hcl | 110 | $19K |
| Hydrocodone Bitartrate | 42 | $17K |
| Naloxegol Oxalate | 22 | $15K |
| Pregabalin | 270 | $13K |
| Fentanyl | 175 | $13K |
Prescribing Profile
33
Unique Drugs
43.0
Anomaly Score
Patient Profile
67
Avg Age
63%
Female
1.89
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About